Volver a Agenda
Session Chair(s)
Peter S. Miele, MD
Medical Officer, Division of Antiviral Products, OND, OMPT, OAP, CDER
FDA, United States
James D. Thompson, PHD
Vice President, Pharmaceutical Development
Quark Pharmaceuticals Inc., United States
Speaker(s)
Phase 2 Data on ALN-RSV01 for the Treatment of Bronchiolitis Obliterans Syndrome in RSV-infected Lung Transplant Patients
Jared A. Gollob, MD
Alnylam Pharmaceuticals, Inc., United States
Vice President, Clinical Research
Ebola
Ian MacLachlan, PHD
Tekmira Pharmaceuticals Corporation, Canada
Executive Vice President and Chief Scientific Officer
iCo-007 in Treatment of Diabetic Macular Edema
Peter Hnik, MD
iCo Therapeutics, Inc., Canada
Chief Medical Officer
¿Tiene una cuenta?